Chae J, Hart R
Department of Physical Medicine and Rehabilitation, MetroHealth Medical Center, Case Western Reserve University, Cleveland, Ohio 44109-1998, USA.
Am J Phys Med Rehabil. 1998 Nov-Dec;77(6):516-22. doi: 10.1097/00002060-199811000-00013.
Neuromuscular stimulation may facilitate motor recovery after stroke or brain injury, reduce shoulder pain associated with hemiplegia, and reduce cerebral spasticity. However, the discomfort of surface neuromuscular stimulation significantly limits the clinical implementation of this modality for persons with hemiplegia. The study contained herein tests the hypothesis that stroke and brain injury survivors with chronic hemiplegia (>6 mo) and intact sensation tolerate percutaneous intramuscular stimulation better than surface stimulation. Four stroke and two traumatic brain injury survivors participated in the study contained within this article. Each subject received three pairs of percutaneous and surface stimulations of the paretic finger extensors. The order of the type of stimulation within each pair was randomly assigned. The stimulation parameters for each type of stimulation were normalized to produce the same torque at the metacarpophalangeal joint. Subjects rated their perceived level of discomfort using a 10-cm visual analog scale and the McGill Pain Questionnaire. A blinded evaluator administered the pain measures. Percutaneous stimulation was associated with significantly lower discomfort as reflected by the visual analog scale (0.74 v 3.3; 95% confidence interval of difference, -3.84, -1.28). The McGill Pain Questionnaire produced similar results with percutaneous stimulation associated with a significantly fewer number of words chosen to describe the discomfort (0.87 v 3.30; 95% confidence interval of difference, -3.50, -1.30) and significantly lower Pain Rating Index (1.47 v 6.27; 95% confidence interval of difference, -7.77, -1.83). Data suggest that percutaneous intramuscular stimulation is significantly better tolerated than surface stimulation and that percutaneous stimulation may enhance patient compliance with neuromuscular stimulation treatments.
神经肌肉刺激可能有助于中风或脑损伤后的运动恢复,减轻与偏瘫相关的肩部疼痛,并减轻大脑痉挛。然而,表面神经肌肉刺激带来的不适显著限制了这种治疗方式在偏瘫患者中的临床应用。本文中的研究检验了这样一个假设:患有慢性偏瘫(超过6个月)且感觉完好的中风和脑损伤幸存者对经皮肌内刺激的耐受性优于表面刺激。四名中风患者和两名创伤性脑损伤幸存者参与了本文中的研究。每位受试者的患侧手指伸肌都接受了三对经皮和表面刺激。每对刺激类型的顺序是随机分配的。每种刺激类型的刺激参数都进行了标准化,以在掌指关节处产生相同的扭矩。受试者使用10厘米视觉模拟量表和麦吉尔疼痛问卷对他们感觉到的不适程度进行评分。一名不知情的评估者进行疼痛测量。经皮刺激带来的不适明显更低,这在视觉模拟量表上有所体现(0.74对3.3;差异的95%置信区间为-3.84,-1.28)。麦吉尔疼痛问卷得出了类似的结果,经皮刺激时用于描述不适的词汇数量明显更少(0.87对3.30;差异的95%置信区间为-3.50,-1.30),疼痛评级指数也明显更低(1.47对6.27;差异的95%置信区间为-7.77,-1.83)。数据表明,经皮肌内刺激的耐受性明显优于表面刺激,并且经皮刺激可能会提高患者对神经肌肉刺激治疗的依从性。